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Abstract
Background: Recently we reported a nanocontainer based reduction triggered release system through an engineered 
transmembrane channel (FhuA Δ1-160; Onaca et al., 2008). Compound fluxes within the FhuA Δ1-160 channel protein 
are controlled sterically through labeled lysine residues (label: 3-(2-pyridyldithio)propionic-acid-N-hydroxysuccinimide-
ester). Quantifying the sterical contribution of each labeled lysine would open up an opportunity for designing 
compound specific drug release systems.
Results: In total, 12 FhuA Δ1-160 variants were generated to gain insights on sterically controlled compound fluxes: 
Subset A) six FhuA Δ1-160 variants in which one of the six lysines in the interior of FhuA Δ1-160 was substituted to 
alanine and Subset B) six FhuA Δ1-160 variants in which only one lysine inside the barrel was not changed to alanine. 
Translocation efficiencies were quantified with the colorimetric TMB (3,3',5,5'-tetramethylbenzidine) detection system 
employing horseradish peroxidase (HRP). Investigation of the six subset A variants identified position K556A as 
sterically important. The K556A substitution increases TMB diffusion from 15 to 97 [nM]/s and reaches nearly the TMB 
diffusion value of the unlabeled FhuA Δ1-160 (102 [nM]/s). The prominent role of position K556 is confirmed by the 
corresponding subset B variant which contains only the K556 lysine in the interior of the barrel. Pyridyl labeling of K556 
reduces TMB translocation to 16 [nM]/s reaching nearly background levels in liposomes (13 [nM]/s). A first B-factor 
analysis based on MD simulations confirmed that position K556 is the least fluctuating lysine among the six in the 
channel interior of FhuA Δ1-160 and therefore well suited for controlling compound fluxes through steric hindrance.
Conclusions: A FhuA Δ1-160 based reduction triggered release system has been shown to control the compound flux 
by the presence of only one inner channel sterical hindrance based on 3-(2-pyridyldithio)propionic-acid labeling 
(amino acid position K556). As a consequence, the release kinetic can be modulated by introducing an opportune 
number of hindrances. The FhuA Δ1-160 channel embedded in liposomes can be advanced to a universal and 
compound independent release system which allows a size selective compound release through rationally re-
engineered channels.
Introduction
A channel protein that is embedded in an impermeable
membrane offers the possibility to develop novel trig-
gered drug release systems with potential applications in
synthetic biology (pathway engineering), and medicine
(drug release). So far only FhuA [1], OmpF [2-4], Tsx [5]
and MscL [6] have been reconstituted functionally into
synthetic block copolymers or lipid membranes.
FhuA is a large monomeric transmembrane protein of
714 amino acids located in the E. coli outer membrane
folded into 22 anti-parallel β-strands and two domains
[7]. By removing the "cork" domain (deletion of amino
acids 5-160 [8,9]) the resulting deletion variant behaves as
a large passive diffusion channel (FhuA Δ1-160) [1].
FhuA and engineered variants have a significantly wider
channel than OmpF (elliptical cross section of OmpF is
7*11 Å [10] whereas FhuA is 39*46 Å [1]) allowing the
translocation of even single stranded DNA [11]. Recently
we reported an exclusive translocation of calcein through
an engineered transmembrane FhuA Δ1-160 which had
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Page 2 of 9been embedded in a tri-block copolymer membrane
PMOXA-PDMS-PMOXA; where PMOXA = poly(2-
methyl-2-oxazoline) and PDMS = poly(dimethyl silox-
ane); and could be opened up through a reduction trig-
gered system [12]. The reported calcein release kinetics
were strongly modulated by the size of employed lysine-
labeling reagents [12]. Twenty nine lysines are present in
the FhuA Δ1-160; 19 lysines located on the protein sur-
face, 6 are inside the channel, and 4 are at the barrel rim
[12]. The 19 lysines on the FhuA surface point into the
outer membrane and are after purification covered by
oPOE rendering pyridyl-labeling unlikely.
An average of four lysine residues per FhuA Δ1-160 was
determined to be pyridyl labeled [12]. Based on the
hypothesis that the 6 lysine inside the channel might
mainly be responsible for restricting compound fluxes,
two subsets of FhuA Δ1-160 variants were generated. In
the six subset (A) variants only one of the six lysines in
channel interior was substituted by alanine and in the six
subset (B) variants only one lysine remained in the chan-
nel interior whereas all other five were substituted to ala-
nine. For the in total 12 investigated FhuA Δ1-160
variants a HRP based colorimetric TMB (3,3',5,5'-tetram-
ethylbenzidine) detection system [13,14] was employed
for quantifying the sterical hindrance of pyridyl-labeled
lysines on the TMB substrate. The colorimetric HRP/
TMB detection was preferred over the previously
reported calcein detection system due to a higher repro-
ducibility [1,12]. Furthermore liposomes instead of a
polymeric nanocontainer system were selected for char-
acterizing the 12 FhuA Δ1-160 variants due to more sim-
ple and rapid assay procedures [15], despite drawbacks
like leakiness, stability over time [16] and undesired
biomolecule adsorption on the surface [17].
However, the better kinetic results reproducibility
using liposomes compared to polymersomes, where the
FhuA Δ1-160 insertion can be affected by block co-poly-
mer poly-dispersity and traces of residual chemicals, sug-
gested us to use liposomes correcting the kinetic results
by the small leakage contribution (see Table 1). To our
best knowledge we report a first detailed mutational
study on a transmembrane channel protein to gain, on
the molecular level, first insights on the sterically con-
trolled diffusion of TMB through the FhuA channel inte-
rior modulated by labeled lysines. Interestingly only one
single lysine position is the main responsible of the TMB
diffusion.
Results
FhuA Δ1-160 based compound release system
Figure 1 shows a FhuA Δ1-160 based compound release
system where FhuA Δ1-160 is embedded in a lipid mem-
brane (left) together with the colorimetric HRP/TMB
reporter used for quantifying TMB translocation (right).
HRP based colorimetric TMB detection system
TMB as chromogen has been developed and widely used
in enzyme immunoassays (EIA) employing horseradish
peroxidase [13,14]. Besides, the colorimetric HRP/TMB
detection system proved to be more reproducible than
the previously employed calcein assay which generates a
fluorescence signal upon release of self-quenching calcein
from liposomes into the surrounding solution.
The HRP/TMB detection system is based on a two step
consecutive oxidative reactions ABC (A = TMB; B
and C = first and second TMB oxidation products, see
Figure 1) catalyzed by HRP in presence of hydrogen per-
oxide. Each single step is a pseudo-second order rate
reaction with a reported second order rate constant
(myeloperoxidases) [14] of: kAB = 3.6*106 M-1 s-1 and
kBC = 9.4*105 M-1 s-1. The final TMB oxidation product
C is unstable out of very acidic conditions [13] and the
intermediate based on the first oxidation product B is
used as reaction reporter, explaining the absorbance drop
in time (see Additional file 1). The total amount of encap-
sulated HRP was not detectable though using the Soret
absorption band. However kinetic data reproducibility
was confirmed basing on a three data set for each mea-
surement.
FhuA Δ1-160 lysine positions and diffusion limited TMB 
translocation
Figure 2 shows the six lysine residues in the FhuA Δ1-160
inner channel which upon labeling might be responsible
to modulate sterically the diffusion through the channel
protein. In total 12 FhuA Δ1-160 variants were generated
to identify the lysine(s) which might limit TMB flux
through FhuA Δ1-160 inner channel. Two subsets of six
FhuA Δ1-160 variants were generated. Subset A) contains
FhuA Δ1-160 variants in which one of the six lysines in
the interior of FhuA Δ1-160 was substituted to alanine;
subset B) contains six FhuA Δ1-160 variants in which
only one lysine was not changed to alanine. Table 1 sum-
marizes for these two subsets the TMB conversions. TMB
conversions were determined by diffusion limited trans-
location through the FhuA Δ1-160 [12] inner channel
(Additional file 1: Figure S1 and S2) using a previously
reported colorimetric HRP/TMB detection system [1,13].
HRP has been entrapped in the liposome harboring
FhuA Δ1-160 variants by using film hydration method
coupled with extrusion. In this method, the lipid
amphiphile is brought in contact with the aqueous
medium containing HRP and FhuA Δ1-160 in its dry
state and is subsequently hydrated to yield vesicles. After
homogenization and purification of the resultant lipo-
somes, the TMB conversion was initiated by supplement-
ing TMB (10 μl) to the aqueous solution. Background
conversions of TMB due to liposome instabilities or
translocation through the membrane in absence of FhuA
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FhuA Δ1-160 variant 
reconstituted in liposomes
Position(s) of 
LysAla 
Substitution(s)
TMB conversion 
[nM]/s
*True averaged 
TMB conversion 
[nM]/s
**TMB conversion 
ratio
Controls Lacking FhuA Δ1-160 - 13 ± 2 - 1
Unlabeled FhuA Δ1-160 - 102 ± 5 89 7.9
Fully labeled FhuA Δ1-160 starting 
variant
- 15 ± 4 2 1.2
Subset A K167A 167 59 ± 2 46 4.5
K344A 344 52 ± 1 39 4
K364A 364 20 ± 3 7 1.5
K537A 537 76 ± 3 63 5.9
K556A 556 97 ± 4 84 7.5
K586A 586 14 ± 1 1 1.1
Subset B K167 344, 364, 537, 556, 586 22 ± 2 9 1.7
K344 167, 364, 537, 556, 586 23 ± 1 10 1.8
K364 167, 344, 537, 556, 586 30 ± 3 17 2.3
K537 167, 344, 364, 556, 586 21 ± 3 8 1.6
K556 167, 344, 364, 537, 586 16 ± 1 3 1.2
K586 167, 344, 364, 537, 556 35 ± 2 22 2.7
Lambert Beer law was used with an extinction coefficient of 3.9 × 10-4 M-1 cm-1 for the first TMB oxidation product. Two subsets (A & B) of FhuA 
Δ1-160 variants were apart from controls analyzed. FhuA Δ1-160 variants of subset A contain a single lysine to alanine substitution while subset 
B contain five lysine to alanine substitutions. All FhuA Δ1-160 variants are pyridyl-labeled except two controls (liposome lacking FhuA Δ1-160 
and the unlabeled FhuA Δ1-160). "*": The true TMB conversion is calculated from the TMB-conversion of FhuA Δ1-160 variant subtracted by the 
TMB conversion of the background lacking FhuA Δ1-160; "**": TMB conversion ratio represents a ratio between TMB conversions of pyridyl-
labeled FhuA Δ1-160 variants and the liposome control lacking FhuA Δ1-160.
Δ1-160 were determined to be 13 [nM]/s (Table 1). Fur-
ther control experiments were based on: liposomes har-
boring unlabeled FhuA Δ1-160 and the fully pyridyl-
labeled FhuA Δ1-160 (starting variant). A TMB conver-
sion of 102 [nM]/s (unlabeled FhuA Δ1-160) and 15
[nM]/s (pyridyl-labeled FhuA Δ1-160; starting variant)
were reached, upon optimizing liposome preparation,
and the TMB assay. The 7.9-fold higher TMB conversion
in the unlabeled FhuA Δ1-160 translates an excellent
detection system to monitor differences in TMB translo-
cation through the twelve FhuA Δ1-160 variants.
TMB conversion of the six subset A variants
The aa-position 556 has a major impact on TMB conver-
sion: K556A substitution increases TMB conversion to 97
[nM]/s which is close to the value of the FhuA Δ1-160
unlabeled variant. A further TMB important blocking
position is found by the substitution K537A increasing
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order of increased TMB conversion has been observed
for subset A variants: 586 < 364 < 344 < 167 < 537 < 556.
TMB conversion of the six subset B) variants
Subset B variants of FhuA Δ1-160 have in the inner chan-
nel only one labeled pyridyl-lysine. For pyridylated posi-
tion 556, a reduction of the translocation to 16 [nM]/s
was achieved. The latter proves impressively that a single
labeled lysine can efficiently and independently from all
other labeled lysines block TMB translocation through
FhuA Δ1-160. For position 537 a cooperative effect can
be observed since the subset B variant shows a signifi-
cantly less pronounced TMB blocking as expected from
the corresponding subset A variant. Similar to the subset
A) variants the following increased TMB conversion has
been observed for the subset B variants: 586 > 364 > 344 >
167 > 537 > 556.
Differences in the absolute values between the two
experimental data sets can likely be attributed to pyridyl
labeling efficiencies, i.e. inner channel sites have a lower
probability to get labeled once lysines on the protein ores
are labeled or when multiple sites are labeled (Additional
file 1: Figure S3). Further experimental details on the
TMB conversion calculations and controls (Additional
file: Figure S1 and S2), CD-spectral measurements on
secondary structure stability of FhuA Δ1-160 (Additional
file 1: Figure S3), size measurements of liposomes (Addi-
tional file 1: Figure S4 and S5) and simulation details, can
be found in the Additional file 1.
Molecular Dynamics simulations to investigate the key 
modulating position 556
A working hypothesis for controlling the compound flux
in the inner FhuA Δ1-160 precisely is a defined and rigid
conformation of the blocking lysine residue. Lysine fluc-
tuations of all six FhuA Δ1-160 have been directly corre-
lated to the B factors deduced from Molecular Dynamics
MD trajectories in a first simulation (see Additional file
1). The B factor analysis indicates the dynamic mobility of
an atom or group of atoms. The concept is derived from
the X-ray scattering/crystallography theory, alternatively
known as "temperature-factor" or "Debye-Waller factor"
[18]. Table 1 suggests that the amino acid position 556 is a
key residue in modulating the compound flux through
the inner channel. Interestingly a general trend between
low B factors values of the unlabeled FhuA Δ1-160 (Fig-
ure 3) and translocation importance (experimental
results; Table 1), has been found. Again the most impor-
tant position 556 is in the B factor analysis the least
mobile one.
Figure 1 Schematic representation of functionalized liposome system. The FhuA Δ1-160 channel protein embedded in the liposomal lipid 
membrane (left panel) employed as reduction triggered gateway for the in/out diffusion of TMB and hydrogen peroxide (right panel) used in the HRP/
TMB colorimetric assay.
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of 39 Å and 46 Å on the "top" part and a reduced cross-
section on the "lower" exit of the barrel, 29 Å and 19 Å.
K556 is placed in a rigid β-barrel at the "lower" cross-sec-
tion (Figure 2) which originally interacts with the fer-
richrome peptide and TonB protein [19] for further iron
translocation. Other lysines are located on the opposite
site K167, K537 and K586 (placed near the top cross-sec-
tion) or underneath (K344; lower cross-section). As indi-
cated by B values the positions K556, K167 and K537
have the higher blocking effects which are in accordance
to the experimental results in corresponding subset A
and B variants though no simulations on the pyridyl-
labeled starting variant FhuA Δ1-160, has been per-
formed (see Additional file 1 for further discussion).
In summary, experimental results and first computa-
tional simulations indicate that the rigidity of the labeled
positions play an important role in generating FhuA Δ1-
160 channels with a defined and "non-fluctuating" pore
size. Fluctuations in pore sizes of FhuA Δ1-160 will
reduce the discriminating power to control compound
fluxes and are therefore an important prerequisite for a
universal compound release system that can rapidly be
re-engineered to match the compound size. Following up
computational simulations are required to investigate in
detail the roles of the pyridyl-label, to investigate cooper-
ative effects of labeled lysine residues and taking labeling
efficiency and perturbations of protein structure after
labeling into account. Further FhuA Δ1-160 engineering
efforts will be based on subset B) variant K556 to further
advance the control of compound fluxes through the
FhuA Δ1-160 channel, especially for low molecular
weight compounds.
Conclusions
Molecular understanding of the sterically controlled dif-
fusion in FhuA Δ1-160's inner channel is an important
prerequisite to develop a universal compound release sys-
tem that can rapidly be re-engineered for a "time and
dose-dependent" compound release.
Six lysine residues were systematically analyzed in two
subsets of engineered FhuA Δ1-160 channels. Analysis of
12 variants identified position K556 as a key substitution
to sterically control compound fluxes through the inner
channel of FhuA Δ1-160 embedded in liposome mem-
brane. A first B-factor analysis based on MD simulations
identified position K556 as the least fluctuating lysine
among the six investigated lysines suggesting a correla-
tion between flexibility and steric control of TMB com-
pound translocation through the inner FhuA Δ1-160
channel. The subset B variant K556 of FhuA Δ1-160 rep-
resents therefore an excellent starting point to under-
Figure 2 Structural model of FhuA Δ1-160 deletion variant. Side view (left); top view (right)) harboring the six lysine residues (K167, K344, K364, 
K537, K556 and K586) in the inner channel part. Lysine residues are pyridyl-labeled. FhuA Δ1-160 variant structures were energy minimized using Ac-
celerysProgram Suite, Version 2.0 (see Additional file 1).
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compound flux through engineered FhuA Δ1-160. Based
on these results it seems promising that the reduction
triggered release system can be advanced to a universal
and compound independent release system which allows
a size selective compound release through rationally re-
engineered FhuA Δ1-160 channels.
Methods
All chemicals used were of analytical reagent grade or
higher quality, purchased from Sigma-Aldrich Chemie
(Taufkirchen, Germany) and Applichem (Darmstadt,
Germany) if not stated otherwise. A thermal cycler (Mas-
tercycler gradient; Eppendorf, Hamburg, Germany) and
thin-wall PCR tubes (Mμlti-ultra tubes; 0,2 ml; Carl Roth,
Karlsruhe, Germany) were used in all PCRs.
1. Site-directed mutagenesis
Six lysines located in the FhuA Δ1-160 channel were sub-
stituted by alanine using QuikChange (developed by
Stratagene; La Jolla, CA, USA) [20] derived SDM proto-
col generating two subsets (A & B; Table 1) of FhuA Δ1-
160 variants. Table 2 lists the primers employed for SDM.
The SDM was performed by using a two-stage PCR
protocol [21]: first stage: one cycle (95°C, 1 min), three
cycles (95°C, 30 s; 55°C, 1 min; 68°C, 2 min) and a second
stage: one cycle (95°C, 1 min), 15 cycles (95°C, 30 s; 55°C,
1 min; 68°C, 2 min) and one cycle (68°C, 25 min). In each
reaction were employed template FhuA Δ1-160 (25 ng), a
primer set (see Table 2; 200 nM each), dNTP mix (200
μM) and Pfu DNA polymerase (1 U) in Pfu reaction buf-
fer (2 × 25 μl total volume, for stage one). In stage one for
each primer the extension reaction is performed in a sep-
arate PCR tube and subsequently pooled for the stage 2
PCR. In Stage 2 additional Pfu DNA polymerase (0.02 U)
is supplemented before starting the second PCR. For
digestion of parental DNA, DpnI (10 U; 1 h, 37°C) is sup-
plemented to the PCR mix. All 12 FhuA Δ1-160 variants
were fully sequenced to assure lysine to alanine substitu-
tions and lack of additional mutations. Amount of DNA
after PCR was quantified using a NanoDrop photometer
(NanoDrop Technologies, Waltham, Massachusetts,
USA).
2. Expression, extraction and purification of FhuA variants
FhuA Δ1-160 variants were expressed, extracted and
purified as previously described [1] with several modifi-
Figure 3 B-factors of the Lys chains averaged on 10 ns of MD simulation.
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formed into the expression host Escherichia coli BE strain
BL 21 (DE3) omp8 (F- hsdSB (rB- mB-) gal ompT dcm (DE3)
Δlamb ompF::Tn5 ΔompA ΔompC) [22] . An overnight
culture (TY media, 25 ml) [12] was prepared and used to
inoculate expression media (inoculate 20 ml; TY
medium, 250 ml) for FhuA Δ1-160 production (1-L shak-
ing flask; 250 rpm, 37°C, 70°C humidity//Infors HT Mul-
titron, Bottmingen, Switzerland). When the OD578
reached 0.7, FhuA Δ1-160 protein expression was
induced with IPTG (final concentration of 1 mM). Cells
were grown (37°C) until the OD578 reached 2.0-2.5 and
harvested (20 min, 3220 rcf, 4°C//Eppendorf 5810R;
Hamburg, Germany). Cells were resuspended in lysis buf-
fer (12 ml; pH 8.0, 20 mM Tris, 2.5 mM MgCl2, 0.1 mM
CaCl2, 1 mM PMSF), cooled on ice and disrupted by
passing through a high-pressure homogenizer (3×, 2000
bar//Emulsiflex-C3, Avestin Inc., Ottawa, Canada). The
disrupted cell suspension was mixed with FhuA Δ1-160
extraction buffer (1 ml; pH 8.0, 20 mM phosphate buffer,
2.5 mM MgCl2, 0.1 mM CaCl2, 20% Triton X-100) and
incubated (1 h, 100 rpm, 37°C//Infors HT Multitron,
Bottmingen, Switzerland). The outer membrane fractions
were isolated by centrifugation (45 min, 39,700 rcf, 4°C//
Avanti J-20XP, Beckman Coulter, Fullerton, USA) and
resuspended in pre-solubilization buffer (9 ml; pH 8.0, 20
mM phosphate buffer, 1 mM EDTA, 0.1% oPOE, 1 mM
PMSF) [23]. The resuspended outer membrane fractions
were subjected to a further incubation (1 h, 200 rpm,
37°C//Infors HT Multitron, Bottmingen, Switzerland)
and were subsequently isolated by centrifugation (45 min,
109,760 rcf, 4°C//Beckman Optima LE-80K Ultracentri-
fuge, Fullerton, USA). In the final step the isolated pellet
was resuspended in solubilization buffer (9 ml; pH 8.0, 20
mM phosphate, 1 mM EDTA, 3% oPOE, 1 mM PMSF)
and membrane fractions were removed by centrifugation
(45 min, 109,760 rcf, 4°C//Avanti J-20XP, Beckman
Coulter, Fullerton, USA). The supernatant containing
FhuA Δ1-160 was concentrated using ultra-filtration (20
min, 3220 rcf, RT//Eppendorf 5810R Centricon YM30;
Millipore, Bedford, USA). Purity of extracted fractions
was controlled by protein gel electrophoresis and compa-
rable to previously reported values [24]. Protein concen-
trations were determined using the standard BCA kit
(Pierce Chemical Co, Rockford, USA).
Table 2: Primers used for Site Directed Mutagenesis (SDM)
Sequence Name Sequence 5' to 3'
FhuA Δ1-160 K167A Fwd CCGCTGAAAGAAGTTCAGTTTGCGGCCGGTACTGACAGCC
FhuA Δ1-160 K167A Rev GGCTGTCAGTACCGGCCGCAAACTGAACTTCTTTCAGCGG
FhuA Δ1-160 K344A Fwd GGCCATTATCTGGCACGTGCGTACGTCGTTGATGATGAGAAG
FhuA Δ1-160 K344A Rev CTTCTCATCATCAACGACGTACGCACGTGCCAGATAATGGCC
FhuA Δ1-160 K364A Fwd GATACCCAGTTGCAGAGCGCGTTTGCCACTGGCGATATCG
FhuA Δ1-160 K364A Rev CGATATCGCCAGTGGCAAACGCGCTCTGCAACTGGGTATC
FhuA Δ1-160 K537A Fwd GCAGTATGAAGTCGGCGTGGCGTATGTACCGGAAGATCG
FhuA Δ1-160 K537A Rev CGATCTTCCGGTACATACGCCACGCCGACTTCATACTGC
FhuA Δ1-160 K556A Fwd GCCGTGTATAATCTCACTGCGACCAACAACCTGATGGCGG
FhuA Δ1-160 K556A Rev CCGCCATCAGGTTGTTGGTCGCAGTGAGATTATACACGGC
FhuA Δ1-160 K586A Fwd CGTAGAAATCGAAGCGGCGGCGGCGCTGTCGGCGAG
FhuA Δ1-160 K586A Rev CTCGCCGACAGCGCCGCCGCCGCTTCGATTTCTACG
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DMSO containing 3-(2-pyridyldithio) propionic acid N-
hydroxysuccinimide ester (250 μl, 38 mM) was added
drop-wise into FhuA Δ1-160 (750 μl, 4.3 μM) in phos-
phate buffer (pH 7.4, 0.2 M Na2HPO4, 0.2 M NaH2PO4,
3% oPOE) and stirred (1 h, 3000 rpm, RT//RCT basic
IKAMAG, IKA-Werke GmbH, Staufen, Germany). Final
concentration of DMSO and oPOE in the solution was
25% and 1.5%, respectively. The latter solution was used
for formation of nanocompartments loaded with HRP
(2.9 U/ml).
4. Liposome preparation methodology
The film hydration method coupled with the mechanical
dispersion technique by filter extrusion was used [25] for
liposome preparation. Conventional methods of lipo-
some production involves three basic stages: drying of
the lipid solution from organic solvents, dispersion of lip-
ids into the aqueous media, homogenization, and purifi-
cation of the resultant liposomes with subsequent
analysis of the final product [26]. E. coli total lipid extract
(Avanti Polar Lipids, Inc., Alabaster, Alabama, USA) is a
chloroform extract of the respective tissue. A mixture of
E. coli total lipid extract (500 μl, 10 mg) and methanol
(1:1, v/v) were used to form a thin lipid film on round-
bottom flask under reduced pressure by using a rotary
evaporator (Büchi Labortechnik AG, Flawil, Switzerland).
The aqueous solution containing phosphate buffer (pH
7.4, 0.2 M Na2HPO4, 0.2 M NaH2PO4), FhuA Δ1-160 (3.2
μM final concentration) and HRP (2.9 U/ml) for entrap-
ment in the interior of the vesicles was supplemented and
the thin lipid film was hydrated overnight in a 30°C water
bath. Nanocompartments encapsulating HRP, harboring
FhuA Δ1-160 as well as amino group labeled FhuA Δ1-
160 were extruded using Avanti Lipid 1 ml syringes (Ala-
baster, Alabama, USA), an Avanti Lipid extrusion appara-
tus (Alabaster, Alabama, USA) and a Bibby Heating block
(Staffordshire, UK). Three polycarbonate membranes
(Millipore Corporation, Bedford, MA, USA) with pore
sizes of 1 μm, 0.4 μm and 0.2 μm were used with the
extrusion equipment in a sequential manner to form uni-
form spherically shaped nanocompartments [27]. Nano-
compartments were purified by gel filtration using
Sepharose 4B (Fluka, Cat. no. 84962) in phosphate buffer
(pH 7.4, 0.2 M Na2HPO4, 0.2 M NaH2PO4). Average
diameters of nanocompartments were routinely deter-
mined using a Zeta-Sizer (Zeta-Sizer Nano Series;
Malvern, Worcestershire, UK//Additional file 1: Figure
S5).
5. TMB assay with nanocompartments
TMB (Sigma Cat. N°: T 0440) assay was selected as a con-
version reporter system. Pre-prepared TMB/H2O2 solu-
tion were used in the kinetic measurement of the TMB
oxidation by the HRP [13,14]. The oxidation of TMB by
the HRP/H2O2 system yields a blue and subsequently a
yellow colored reaction product. Initial TMB oxidation
kinetics are quantified by measuring an absorption maxi-
mum at 370 nm [14] using a microtiter plate reader
(Omega Series; BMG LABTECH; Offenburg, Germany).
TMB solution (10 μl) was supplemented to a 100 μl dis-
persion consisting of purified nanocompartments (in
phosphate buffer, pH 7.4, 0.2 M Na2HPO4, 0.2 M
NaH2PO4). Detailed kinetic results of the TMB assay of
FhuA Δ1-160 variants are available in Additional file 1:
Figure S1.
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